IFGL Refractories consolidated PAT jumps 58% YoY, revenue +13%, on US profit turnaround

IFGL Refractories' consolidated (primary) Q1 FY27 (quarter ended June 30, 2026) revenue rose 12.9% YoY to ₹512.4 Cr (₹454.0 Cr in Q1 FY26; +6.1% QoQ from ₹483.0 Cr), while PAT jumped 57.8% YoY to ₹17.06 Cr (₹10.81 Cr a year ago; +19.5% QoQ from ₹14.28 Cr), taking EPS to ₹2.37 from ₹1.50. Neither this quarter nor the year-ago quarter carried exceptional items, so the growth is entirely underlying with no one-off adjustment needed. Standalone (India-only) PAT grew a much softer 7.1% YoY to ₹15.78 Cr on revenue of ₹296.6 Cr — the wide gap versus consolidated confirms the growth is coming almost entirely from overseas operations rather than the domestic book.

Net margin expanded to 3.33% from 2.37% a year ago, helped by a lower effective tax rate (26.3% vs 28.75% in Q1 FY26). But operating profitability actually compressed: EBITDA margin fell to roughly 7.2% from ~7.9% both YoY and QoQ, driven by raw material costs rising to 52.6% of revenue from 47.1% in Q1 FY26 (+5.6pp), partly offset by a lighter trading mix (purchase of stock-in-trade fell to 1.3% of revenue from 5.6%). Segment data shows exactly where the growth came from: America segment profit (before finance costs/tax) more than doubled to ₹10.84 Cr from ₹6.04 Cr (+79.5% YoY) on revenue up 32.4% to ₹102.2 Cr, and Europe's loss narrowed 18% to ₹7.09 Cr from ₹8.69 Cr — both directly matching management's Q4 FY26 commentary on 'improving profitability' and 'signs of recovery' internationally, particularly the US. India, the segment management flagged as the primary growth driver, grew revenue only 7.4% YoY to ₹292.9 Cr with segment PBT roughly flat (₹23.24 Cr vs ₹23.45 Cr) — domestic growth undershot the 'double-digit' framing even as consolidated topline cleared it on the strength of international ops.

The stock went into the print at ₹227.1, down 2.9% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.

Against management's own FY27 guidance — double-digit growth led by a strong domestic business, with international recovery (especially the US) as a secondary tailwind — this quarter effectively inverts that script: the double-digit consolidated growth (12.9%) and PAT beat were delivered by the overseas turnaround rather than domestic strength, so it is a beat on substance but not on the stated mix. No formal analyst consensus for this quarter could be found (thin sell-side coverage typical of this market cap), so vs-street is unknown; no separate management press release was available beyond the regulatory filing. Alongside results, the board approved a 21.5% final dividend (₹2.15/share) and the AGM was held August 5; subsequent-to-quarter developments include incorporation of a wholly-owned Saudi subsidiary (July 11) and completion of the Czech subsidiary's voluntary liquidation (July 1) — portfolio-shaping moves, not in-quarter financial drivers. Separately, the proposed Marvels JV application for the Bhachau, Gujarat site was closed by the relevant government authority over location concerns, requiring a fresh application with an alternative site — a minor delay to a growth project, not a financial hit this quarter.